Search
for
Sort by
Research 481–510 of 1000+
- Roles of steroid sulfatase in brain and other tissues
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Is polycystic ovary syndrome a sexual conflict? A review
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Hirsutism: A Clinico-investigative Study
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Postmenopausal virilization after spousal use of topical androgens
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options
- Systemic causes of hair loss
- Genetic basis of polycystic ovary syndrome
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Treatment of androgenic disorders with dexamethasone: Dose-response relationship for suppression of dehydroepiandrosterone sulfate
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Congenital adrenal hyperplasia
- Therapeutic options in the polycystic ovary syndrome
- Current aspects of polycystic ovary syndrome: A literature review
- Alopecia and Hirsuties
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Prevalence of hyperandrogenism in Iraqi women with polycystic ovary syndrome